Device and method for monitoring a vascular access for an extracorporeal blood treatment

US9050420B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9050420-B2
Application numberUS-201113578306-A
CountryUS
Kind codeB2
Filing dateFeb 7, 2011
Priority dateFeb 12, 2010
Publication dateJun 9, 2015
Grant dateJun 9, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A device and method for monitoring an access to a patient for an extracorporeal blood treatment apparatus with an extracorporeal blood circuit are described, as well as an extracorporeal blood treatment apparatus with a device for monitoring the vascular access. The device and method are based on the monitoring of a characteristic property of the blood, in particular the concentration of haemoglobin in the blood flowing in the arterial blood line of extracorporeal blood circuit I of an extracorporeal blood treatment apparatus A. In the event of an incorrect vascular access, the flow conditions change in the communicating intra- and extracorporeal blood circulation system. These changes in the flow conditions can be detected as a change in the haemoglobin concentration. A disconnection of venous puncture cannula for the patient access is ascertained by a reduction in the haemoglobin concentration in the blood in arterial blood line.

First claim

Opening claim text (preview).

The invention claimed is: 1. A device for monitoring a vascular access to a patient for an extracorporeal blood treatment apparatus with an extracorporeal blood circuit, comprising an arterial blood line with an arterial puncture cannula and a venous blood line with a venous puncture cannula, wherein a blood pump for conveying blood in the extracorporeal blood circuit is disposed in one of the arterial blood line or the venous blood line, the device for monitoring the vascular access comprising: a measuring unit configured to measure a haemoglobin concentration of the blood flowing only in the arterial blood line of the extracorporeal blood circuit; and a control and computing unit configured to determine that there is a disconnection of the venous puncture cannula in an event of a reduction in the haemoglobin concentration of the blood flowing in the arterial blood line as measured by the measuring unit beyond a preset amount. 2. The device according to claim 1 , wherein the control and computing unit comprises a comparison unit configured for comparing a measured haemoglobin concentration with a preset threshold value, and a generation unit configured for generating a control signal when a difference between the measured haemoglobin concentration and the preset threshold value is greater than zero. 3. The device according to claim 1 , wherein the control and computing unit comprises a comparison unit configured to compare a first haemoglobin concentration measured at a first preceding time with a second haemoglobin concentration measured at a second subsequent time, and a generation unit configured to generate a control signal when a difference between the first haemoglobin concentration and the second haemoglobin concentration is greater than a preset threshold value. 4. The device according to claim 1 , further comprising: a measuring unit configured for measuring a cardiopulmonary recirculation, the control and computing unit comprising a comparison unit configured for comparing the measured cardiopulmonary recirculation with preset upper and lower threshold values, wherein the control and computing unit is configured to determine that there is an incorrect vascular access in the event of the reduction in the haemoglobin concentration by an amount which exceeds the preset amount, when the measured cardiopulmonary recirculation lies between the preset upper and lower threshold values. 5. The device according to claim 1 , further comprising: an alarm unit configured to emit at least one of an acoustic, optical or tactile alarm when the control and computing unit ascertains the disconnection of the venous puncture cannula. 6. The device according to claim 1 , wherein the measuring unit configured to measure the haemoglobin concentration includes a measuring unit configured to non-invasively measure the haemoglobin concentration in the blood flowing in the arterial blood line. 7. An apparatus for extracorporeal blood treatment, comprising: the device for monitoring the vascular access to the patient according to claim 1 . 8. The apparatus according to claim 7 , further comprising: a central control unit configured to perform an intervention into machine control when the control and computing unit of the device for monitoring the vascular access ascertains the disconnection of the venous puncture cannula. 9. The apparatus according to claim 8 , wherein the control unit of the blood treatment apparatus is configured to stop the blood pump disposed in the extracorporeal blood circuit as the intervention into the machine control. 10. The apparatus according to claim 8 , wherein the control unit of the blood treatment apparatus is configured to close a shut-off element for shutting off the venous blood line of the blood treatment apparatus as the intervention into the machine control. 11. The device according to claim 1 , wherein the measuring unit does not measure the hemoglobin concentration of the blood flowing in the venous blood line of the extracorporeal blood circuit. 12. The device according to claim 1 , wherein the measuring unit is situated upstream of the blood pump. 13. The device according to claim 1 , wherein the measuring unit is configured to measure only a single characteristic property of the blood. 14. The device according to claim 1 , wherein the measuring unit is configured to measure only the haemoglobin concentration in the blood. 15. A device for monitoring a vascular access to a patient for an extracorporeal blood treatment apparatus with an extracorporeal blood circuit, comprising an arterial blood line with an arterial puncture cannula and a venous blood line with a venous puncture cannula, wherein a blood pump for conveying blood in the extracorporeal blood circuit is disposed in one of the arterial blood line or the venous blood line, the device for monitoring the vascular access comprising: a measuring unit configured to measure a characteristic property of the blood flowing only in the arterial blood line of the extracorporeal blood circuit; and a control and computing unit configured to determine that there is a disconnection of the venous puncture cannula in an event of a change in the characteristic property of the blood flowing in the arterial blood line as measured by the measuring unit beyond a preset amount, wherein the control and computing unit determines the disconnection of the venous puncture cannula solely from the change in the characteristic property.

Assignees

Inventors

Classifications

  • Red blood cells; Erythrocytes · CPC title

  • Glucose concentration · CPC title

  • partial oxygen pressure (P-O2) · CPC title

  • using light, e.g. diagnosis by transillumination, diascopy, fluorescence (photoacoustic A61B5/0093; optical measurement of heart rate A61B5/02416; optical measurement of blood flow A61B5/0261; optical measurement of analytes A61B5/1455) · CPC title

  • Monitoring patency or flow at connection sites; Detecting disconnections · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9050420B2 cover?
A device and method for monitoring an access to a patient for an extracorporeal blood treatment apparatus with an extracorporeal blood circuit are described, as well as an extracorporeal blood treatment apparatus with a device for monitoring the vascular access. The device and method are based on the monitoring of a characteristic property of the blood, in particular the concentration of haemog…
Who is the assignee on this patent?
Zhang Wei, Fresenius Medical Care De Gmbh
What technology area does this patent fall under?
Primary CPC classification A61M1/3653. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).